Platelet to lymphocyte ratio predicts all-cause mortality in patients with carotid arterial disease

Abstract Background. Platelet to lymphocyte ratio (PLR) has been demonstrated as a risk and prognostic marker in many of cardiovascular diseases. A relationship between PLR and severity of carotid stenosis has been shown. The aim of our study was to investigate the relationship between PLR and all cause mortality in patients with carotid arterial disease. Methods. This retrospective study included 146 patients who had been performed selective carotid angiography. Carotid stenosis were graded by the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. Platelet to lymphocyte ratio was calculated as the ratio of platelets to lymphocytes. The end point of the study was all-cause mortality. Results. During median follow-up of 16 months (0-65 months) 15 (10.3%) patients suffered all-cause mortality. 50 patients (34.2%) underwent carotid endarterectomy and 69 patients (47.3%) had non-carotid cardiac surgery. 38 patients (26.02%) had cerebrovascular events (stroke/transient ischemic attack) at admission. NASCET grades were not different between survivors and non-survivors. Non-survivors had significantly lower hemoglobin (Hb) levels (12.7 ± 1.6 g/dL vs. 13.7 ± 1.7 g/dL, p = 0.031) and they were older than survivors (74.2 ± 8.4 years vs. 68.6 ± 8.5 years, p = 0.029). Non-survivors had significantly higher PLR values compared with survivors (190.3 ± 85.6 and 126.8 ± 53.8, p = 0.017). In multivariate analysis, only PLR predicted all-cause mortality in patients with carotid artery stenosis. Conclusion. In our study, higher PLR was associated with increased all-cause mortality.

[1]  A. Bayramoğlu,et al.  Usefulness of platelet to lymphocyte ratio for predicting recurrence of atrial fibrillation after direct current cardioversion , 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[2]  Andrew M. Wilson,et al.  Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography. , 2018, The American journal of cardiology.

[3]  F. Uzunkaya,et al.  The correlation of the platelet-to-lymphocyte ratio with the severity of stenosis and stroke in patients with carotid arterial disease , 2017, Vascular.

[4]  H. Kisacik,et al.  Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction , 2016, Angiology.

[5]  J. Gardin,et al.  Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. , 2016, The American journal of cardiology.

[6]  R. Akdemir,et al.  Usefulness of the platelet‐to‐lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography , 2016, The Kaohsiung journal of medical sciences.

[7]  E. Okuyan,et al.  Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention , 2015, Platelets.

[8]  S. Akdağ,et al.  Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[9]  I. Sari,et al.  Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure , 2015, Arquivos brasileiros de cardiologia.

[10]  C. Ozturk,et al.  The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events , 2015, Platelets.

[11]  M. Aydın,et al.  The Utility of the Platelet–Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction , 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  S. Aydoǧdu,et al.  Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction , 2015, Angiology.

[13]  A. Wiczkowski,et al.  The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation , 2015, Journal of the Saudi Heart Association.

[14]  J. Min,et al.  Diagnostic value of coronary CT angiography in comparison with invasive coronary angiography and intravascular ultrasound in patients with intermediate coronary artery stenosis: results from the prospective multicentre FIGURE-OUT (Functional Imaging criteria for GUiding REview of invasive coronary a , 2014, European Heart Journal-Cardiovascular Imaging.

[15]  H. Kaya,et al.  The association between platelet/lymphocyte ratio and coronary artery disease severity , 2014, Anatolian journal of cardiology.

[16]  A. Barutcu,et al.  Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[17]  M. Ozkan,et al.  Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. , 2014, The American journal of cardiology.

[18]  A. Gerger,et al.  Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients , 2013, PloS one.

[19]  Christian Gieger,et al.  On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies , 2012, BMC Bioinformatics.

[20]  M. Akerman,et al.  Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction , 2012, Journal of Thrombosis and Thrombolysis.

[21]  Shaun P Jackson,et al.  The role of platelets in atherothrombosis. , 2011, Hematology. American Society of Hematology. Education Program.

[22]  R. Hall,et al.  Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. , 2010, American journal of surgery.

[23]  A. Nicolaides,et al.  ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  R. Gibbons,et al.  Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. , 1997, The American journal of cardiology.

[25]  U. Zaleska-Dorobisz,et al.  [Dual source computed tomography in analysis of significance and morphology carotid plaques]. , 2013, Przeglad lekarski.

[26]  G. Moneta,et al.  Correlation of North American Symptomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. , 1993, Journal of vascular surgery.